Forma Therapeutics Garners $25,500,000 Series B Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d4303b05-0ce9-4cac-bb84-8d9d30b4336a&Preview=1
Date 12/1/2009
Company Name Forma Therapeutics
Mailing Address 790 Memorial Drive Cambridge, MA 02139
Company Description FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers.
Proceeds Purposes “With this new funding, FORMA will focus on advancing our internal target-based oncology programs and in parallel, we will continue to pursue non-dilutive collaborations to further build our integrated drug discovery platform,” said Steven Tregay, CEO of FORMA.